Cargando…

Analysis of Bacterial and Fungal Infections after Cytoreduction Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Observational Single-Centre Study

INTRODUCTION: While hyperthermic intraperitoneal chemotherapy (HIPEC) after cytoreduction surgery (CRS) has been shown to improve patient survival and disease-free progression in peritoneal carcinoma (PC) patients, the procedure relates to a high postoperative infection rate. Herein, we report the b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Albukhari, Talat A. M., Nafady-Hego, Hanaa, Elgendy, Hamed, Abd Elmoneim, Hanan M., Nafady, Asmaa, Alzahrani, Abdulaziz M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701354/ https://www.ncbi.nlm.nih.gov/pubmed/31467552 http://dx.doi.org/10.1155/2019/6351874

Ejemplares similares

Perioperative management and postoperative outcome of patients undergoing cytoreduction surgery with hyperthermic intraperitoneal chemotherapy
por: Elgendy, Hamed, et al.
Publicado: (2019)

Short term survival of critically ill COVID-19 Egyptian patients on assisted ventilation treated by either Dexamethasone or Tocilizumab
por: Rashad, Alaa, et al.
Publicado: (2021)

Cytoreduction with hyperthermic intraperitoneal chemotherapy: An anaesthetic challenge
por: Murughan, Kavita, et al.
Publicado: (2014)

Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: A possible prognostic marker
por: Zahran, Asmaa M., et al.
Publicado: (2021)

Corrigendum: Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: A possible prognostic marker
por: Zahran, Asmaa M., et al.
Publicado: (2022)

Pregnancy after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei
por: Campanati, Renato Gomes, et al.
Publicado: (2014)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer
por: Gamboa, Adriana C., et al.
Publicado: (2019)

Is cytoreductive surgery and hyperthermic intraperitoneal chemotherapy indicated in hepatobiliary malignancies?
por: Leigh, Natasha, et al.
Publicado: (2020)

Experiences with cytoreduction surgery plus hyperthermic intraperitoneal chemotherapy in Taiwan
por: Hsieh, Mao-Chih, et al.
Publicado: (2017)

Single-Port Laparoscopic Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy
por: Alshammari, Turki, et al.
Publicado: (2019)

Anesthetic concerns during cytoreductive surgery with hyperthermic intraperitoneal chemotherapy
por: Ryu, Jung-Hee, et al.
Publicado: (2021)

Temperature management during cytoreductive surgery with hyperthermic intraperitoneal chemotherapy
por: Ramirez, Maria F., et al.
Publicado: (2023)

Urgent re-laparotomies in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: Manoğlu, Berke, et al.
Publicado: (2022)

Hematological Alterations after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
por: Pintado, Maria Consuelo, et al.
Publicado: (2023)

A Canadian single-centre experience with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for abdominal malignancies
por: Nassabein, Rami, et al.
Publicado: (2022)

Cytoreductive onco-surgery with combined hyperthermic intraperitoneal chemotherapy and hyperthermic intrathoracic chemotherapy: Perioperative challenges
por: Dattatri, Rohini, et al.
Publicado: (2019)

Recurrence of pseudomyxoma peritonei after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: Mercier, F., et al.
Publicado: (2018)

Intraoperative metabolic changes associated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: Rubio-López, Jesús David, et al.
Publicado: (2023)

Wernicke encephalopathy as rare complication of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: Macrì, Antonio, et al.
Publicado: (2015)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Fluid and temperature remain the culprit!
por: Garg, Rakesh
Publicado: (2018)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in treatment of gastric cancer with peritoneal carcinomatosis
por: Ellison, Lynne M., et al.
Publicado: (2017)

Cirrhosis is not a contraindication to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in highly selected patients
por: Weiss, Anna, et al.
Publicado: (2018)

Preoperative bevacizumab does not increase complications following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: King, Bradley H., et al.
Publicado: (2020)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer
por: Piso, Pompiliu, et al.
Publicado: (2004)

Rhabdomyolysis after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Case Report
por: Bielen, Rob, et al.
Publicado: (2013)

Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer with peritoneal metastasis
por: Lin, En-Kwang, et al.
Publicado: (2016)

Outcomes of multicystic peritoneal mesothelioma treatment with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: Zahid, A, et al.
Publicado: (2020)

Predicting Early and Late Readmissions Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
por: Moon, Eui Whan, et al.
Publicado: (2021)

Coagulopathy and Venous Thromboembolic Events Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
por: Dranichnikov, Paul, et al.
Publicado: (2021)

Safe performance of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with HIV infection
por: Coghill, Anna, et al.
Publicado: (2022)

Quality of life and symptom distress after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: Wang, Ya-Fen, et al.
Publicado: (2022)

Anesthetic management of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A case report
por: Howbora, Nilanjana, et al.
Publicado: (2023)

The risk factors for gastrointestinal anastomotic leak after cytoreduction with hyperthermic intraperitoneal chemotherapy
por: Bisgin, Tayfun, et al.
Publicado: (2023)

Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: patient selection and special considerations
por: Enomoto, Laura M, et al.
Publicado: (2019)

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: Girshally, Ramy, et al.
Publicado: (2016)

A contemporary analysis of morbidity and outcomes in cytoreduction/hyperthermic intraperitoneal chemoperfusion
por: Haslinger, Michelle, et al.
Publicado: (2013)

Surgeons’ Ability to Predict the Extent of Surgery Prior to Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy
por: Hentzen, Judith E. K. R., et al.
Publicado: (2020)

Intensive Care Unit Admission after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Is It Necessary?
por: López-Basave, Horacio N., et al.
Publicado: (2014)

Overall survival and morbidity are not associated with advanced age for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a single centre experience
por: Cheng, Ernest, et al.
Publicado: (2023)

Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a prospective clinical trial and comparative analysis
por: Cho, Chae Yun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lkk25c94nq96tlcoisstvus0t4